Shionogi & Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Minority-Interest-Expense" stands at -0.576 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 09/30/2023.
Shionogi & Co. Ltd.'s first quarter result of -0.007 Billion JPY for the item "Minority Interest Expense" represents an increase of 98.39 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Shionogi & Co. Ltd.'s first quarter result of -0.007 Billion JPY for the item "Minority Interest Expense" represents an increase of 97.88 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Shionogi & Co. Ltd.'s first quarter result of -0.576 Billion JPY for the item "Minority Interest Expense" represents an increase of 35.93 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.861 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 0.861 Billion Japanese Yens.
The 3 year change is 0.424 Billion Japanese Yens.
The 5 year change is 3.93 Billion Japanese Yens.
The 10 year change is -0.679 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Minority Interest Expense | 905,699,262,464.00 |
![]() | Johnson & Johnson - Minority Interest Expense | 486,508,953,600.00 |
![]() | AbbVie Inc - Minority Interest Expense | 399,570,305,024.00 |
![]() | Roche Holding AG - Minority Interest Expense | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Minority Interest Expense | 280,205,508,085.11 |